A one-time experimental treatment shows unprecedented success in slowing Huntington’s disease, according to UCL researchers. FDA review expected in 2026.
Preliminary gene therapy shows 75% reduction in Huntington’s disease progression
A one-time experimental treatment shows unprecedented success in slowing Huntington’s disease, according to UCL researchers. FDA review expected in 2026.